Skip to main content
Top
Published in: Rheumatology International 11/2013

01-11-2013 | Short Communication

Three cases of IgG4-related orbital inflammation presented as unilateral pseudotumor and review of the literature

Authors: Tomoki Origuchi, Hiroki Yano, Hideki Nakamura, Akiyoshi Hirano, Atsushi Kawakami

Published in: Rheumatology International | Issue 11/2013

Login to get access

Abstract

IgG4-related disease is an emerging disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. In IgG4-related disease, tumor-like lesions develop in multiple organs, such as the lacrimal gland, salivary gland, lung, pancreas, kidney, and lymph nodes. We report here three cases of IgG4-related orbital inflammation that presented as unilateral pseudotumors. The patients all were men, with an age range of 65–75 years. The patients had been pointed out unilateral intra-orbital masses, and histopathological examinations revealed marked accumulation of IgG4-positive plasma cells (IgG4/IgG ratio: 51.1–71.6 %) with fibrosis. But storiform fibrosis was seen in only one case, and no obliterative phlebitis was seen. The serum levels of IgG4 were increased to 178–670 mg/dL. The masses had well-defined homogeneous signal intensities, and they were hypo-intense on T1-weighted MR images and iso-intense on T2-weighted MR images. Gadolinium enhanced mass lesions in two cases. All orbital mass lesions responded well to corticosteroid treatment.
Literature
1.
go back to reference Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1–14PubMedCrossRef Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1–14PubMedCrossRef
2.
go back to reference Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21–30PubMedCrossRef Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21–30PubMedCrossRef
3.
go back to reference Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732–738PubMedCrossRef Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732–738PubMedCrossRef
4.
go back to reference Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al (2005) Clinical and pathological differences between Mikulicz’s disease and Sjögren’s syndrome. Rheumatology 44:227–234PubMedCrossRef Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al (2005) Clinical and pathological differences between Mikulicz’s disease and Sjögren’s syndrome. Rheumatology 44:227–234PubMedCrossRef
5.
go back to reference Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M et al (2009) Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 68:1310–1315PubMedCrossRef Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M et al (2009) Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 68:1310–1315PubMedCrossRef
6.
go back to reference Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO (2012) Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol 198:W217–W227PubMedCrossRef Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO (2012) Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol 198:W217–W227PubMedCrossRef
7.
go back to reference Narla LD, Newman B, Spottswood SS, Narla S, Kolli R (2003) Inflammatory pseudotumor. Radiographics 23:719–729PubMedCrossRef Narla LD, Newman B, Spottswood SS, Narla S, Kolli R (2003) Inflammatory pseudotumor. Radiographics 23:719–729PubMedCrossRef
8.
go back to reference Maves CK, Johnson JF, Bove K, Malott RL (1989) Gastric inflammatory pseudotumor in children. Radiology 173:381–383PubMed Maves CK, Johnson JF, Bove K, Malott RL (1989) Gastric inflammatory pseudotumor in children. Radiology 173:381–383PubMed
9.
go back to reference Sanders BM, West KW, Gingalewski C, Engum S, Davis M, Grosfeld JL (2001) Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg 36:169–173PubMedCrossRef Sanders BM, West KW, Gingalewski C, Engum S, Davis M, Grosfeld JL (2001) Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg 36:169–173PubMedCrossRef
10.
go back to reference Pasquali T, Schoenfield L, Spalding SJ, Singh AD (2011) Orbital inflammation in IgG4-related sclerosing disease. Orbit 30:258–260PubMedCrossRef Pasquali T, Schoenfield L, Spalding SJ, Singh AD (2011) Orbital inflammation in IgG4-related sclerosing disease. Orbit 30:258–260PubMedCrossRef
11.
go back to reference Wallace ZS, Khosroshahi A, Jakobiec FA, Deshpande V, Hatton MP, Ritter J et al (2012) IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 57:26–33PubMedCrossRef Wallace ZS, Khosroshahi A, Jakobiec FA, Deshpande V, Hatton MP, Ritter J et al (2012) IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 57:26–33PubMedCrossRef
12.
go back to reference Takahashi H, Yamamoto M, Tabeya T, Suzuki C, Naishiro Y, Shinomura Y et al (2012) The immunobiology and clinical characteristics of IgG4 related diseases. J Autoimmun 39(1–2):93–96 Takahashi H, Yamamoto M, Tabeya T, Suzuki C, Naishiro Y, Shinomura Y et al (2012) The immunobiology and clinical characteristics of IgG4 related diseases. J Autoimmun 39(1–2):93–96
13.
go back to reference Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A et al (2012) Cut off values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4 related disease. Int J Rheumatol 2012:580814 Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A et al (2012) Cut off values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4 related disease. Int J Rheumatol 2012:580814
14.
go back to reference Katsura M, Mori H, Kunimatsu A, Sasaki H, Abe O, Machida T et al (2012) Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology 54(8):873–882 Katsura M, Mori H, Kunimatsu A, Sasaki H, Abe O, Machida T et al (2012) Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology 54(8):873–882
Metadata
Title
Three cases of IgG4-related orbital inflammation presented as unilateral pseudotumor and review of the literature
Authors
Tomoki Origuchi
Hiroki Yano
Hideki Nakamura
Akiyoshi Hirano
Atsushi Kawakami
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2566-2

Other articles of this Issue 11/2013

Rheumatology International 11/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine